2020
DOI: 10.21203/rs.3.rs-129135/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Testing a Breast Cancer Prevention and a Multiple Disease Prevention Weight Loss Programme Among Women Within The UK NHS Breast Screening Programme - A Randomised Feasibility Study

Abstract: Excess weight and unhealthy behaviours (sedentariness, high alcohol and suboptimal diet) are common among women attending breast screening. These factors increase the risk of breast cancer and other diseases. We tested the feasibility and acceptability of a weight loss/ behaviour change programme framed to reduce breast cancer risk (breast cancer prevention programme, BCPP) compared to one framed to reduce risk of breast cancer, cardiovascular disease (CVD) and diabetes (T2D) (multiple disease prevention progr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(5 citation statements)
references
References 29 publications
3
2
0
Order By: Relevance
“…There was no difference in retention or weight loss success between the MDPP and BCPP groups which is consistent with our findings in women in the general population attending breast screening [18]. Prior to this trial it was unclear whether additional personalised CVD and T2D risk to women in the FHRPC would enhance or decrease weight loss success due to a greater response efficacy for CVD and T2D compared to the risk of BC [13,14] or CVD/T2D risk information being less personally relevant to women at increased risk of BC [15].…”
Section: Discussionsupporting
confidence: 91%
See 4 more Smart Citations
“…There was no difference in retention or weight loss success between the MDPP and BCPP groups which is consistent with our findings in women in the general population attending breast screening [18]. Prior to this trial it was unclear whether additional personalised CVD and T2D risk to women in the FHRPC would enhance or decrease weight loss success due to a greater response efficacy for CVD and T2D compared to the risk of BC [13,14] or CVD/T2D risk information being less personally relevant to women at increased risk of BC [15].…”
Section: Discussionsupporting
confidence: 91%
“…Retention at 12 months was just below 60%. This aligns with previous weight loss intervention studies amongst women attending breast screening [18] and women in the general population [40].…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations